Idiopathic Pulmonary Fibrosis and Serum Bank

Last updated: November 27, 2023
Sponsor: Rennes University Hospital
Overall Status: Completed

Phase

N/A

Condition

Idiopathic Pulmonary Fibrosis

Pulmonary Fibrosis

Cystic Fibrosis

Treatment

Blood sample collection

Clinical Study ID

NCT04016168
35RC14_9722
2014-A00268-39
  • Ages > 18
  • All Genders

Study Summary

Idiopathic pulmonary fibrosis (IPF) is the most common form of chronic idiopathic diffuse interstitial lung disease (DILD) in adults. It is a fibroproliferative, irreversible disease of unknown cause, usually progressive, occurring mainly from the age of 60 and limited to the lungs. IPF is a serious disease with a median survival rate at diagnosis of 3 years.

The aim of the study is to set up a biocollection of serum from patients in a context of idiopathic DILD and a possible or confirmed diagnosis of common interstitial lung disease by chest CT.

Patients will be recruited at the consultations of the Rennes Rare Lung Disease Competence Centre. These will be patients in stable condition or in acute exacerbation of IPF.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients seen on an outpatient basis and in stable or acute condition
  • Patient over 18 years of age.
  • The inclusion criteria will be those edited by the American Thoracic Society (ATS) andthe European Respiratory Society (ERS) to diagnosis IPF

Exclusion

Exclusion Criteria:

  • Patients who are unable or unwilling to sign the consent.

Study Design

Total Participants: 903
Treatment Group(s): 1
Primary Treatment: Blood sample collection
Phase:
Study Start date:
October 22, 2014
Estimated Completion Date:
December 28, 2022

Study Description

This study will initially focus on circulating serum CD163 markers, but a broader proteomics approach could be considered in a second phase to look for other markers of lung diseases.

Connect with a study center

  • Rennes University Hospital - Service de Pneumologie

    Rennes, 35033
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.